China’s Pet Boom Has a New Lead Dog

A top pet care player is redefining what it means to travel with pets: not just tolerated, but pampered.

By partnering with top-tier hotels, the company is sniffing out new revenue streams in China’s booming pet tourism sector.

Is this the brand that finally turns cuddles into capital?

Wall Street closed lower on Thursday as tech sector losses and Fed rate cut uncertainty overshadowed a seemingly positive but vague U.S.-China trade meeting.

International Paper (NYSE: IP) just took a billion-dollar charge to sell its cellulose fibers division for $1.5 billion.

That sounds painful on paper, but it’s the company’s way of lightening the load and focusing on what really sticks—packaging and containerboard.

The sale trims away slower segments in Europe and the UK, clearing space for stronger, steadier operations.

You can almost picture the execs holding a “less is more” sign while closing another factory door.

From Pulp to Profit

The paper world has been tough lately, with weak retail demand and rising costs crumpling profit margins.

International Paper’s answer is simple: stop chasing everything and double down where demand still stacks high.

The goal is to turn those endless shipping boxes and packaging lines into predictable, cash-generating machines.

You know a company means business when it stops trying to be everywhere and starts getting really good at one thing.

Folding Toward the Future

The reset may sting short-term earnings, but it frees up capital for better plays ahead. It’s a pivot from bulky to balanced, from reactive to ready.

And if you’re watching where steady returns could reappear, keep International Paper in sight.

The company might be cutting back today, but it’s setting itself up to print profits tomorrow.

Ford Motor Company (NYSE: F) has just announced a recall of 227,000 vehicles across the U.S.

This is a major recall, affecting windshields, seat bolts, and defrosters that may not function properly.

The list includes fan favorites like the Bronco, Lincoln, Explorer, and Econoline vans. You can almost hear every Ford mechanic sighing in unison as another round of repairs hits the schedule.

Deja Vu in Detroit

The timing couldn’t be worse. Ford had just recalled 175,000 vehicles for faulty moonroof deflectors, turning what should’ve been a routine week into a corporate headache.

Each fix chips away at time, money, and public patience. For a brand built on toughness, these small cracks are turning into serious questions about reliability.

The Road Back to Trust

Ford’s challenge now isn’t just about fixing parts; it’s about fixing perception. Buyers want consistency, not constant callbacks, and trust takes longer to rebuild than an engine.

If you’re watching from the sidelines, keep an eye on how Ford manages the next few months.

One good run of quality could turn the story around, but until then, the check-engine light is still blinking.

How many of your investments have truly taken off this year?

Market experts just unveiled 5 stocks positioned for explosive growth — each selected for its potential to double (or more) over the next 12 months.

These picks stand out for their strong earnings momentum, solid fundamentals, and the kind of upside catalysts that have driven past winners to gains of +175%, +498%, even +673%.¹

Opportunities like this don’t last long — and access to this new report is free only until midnight tonight.

[Get the 5 Stocks Set to Double Report – Free Until Midnight]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Snowflake (NYSE: SNOW) isn't building robots or writing code for your chatbot. It's the quiet operator storing and organizing the oceans of data that makes AI possible.

All major tech players, from streaming platforms to banks, use Snowflake's cloud warehouse to operate more intelligently, quickly, and efficiently.

You can't see it, but odds are your favorite app is sitting on its servers right now.

The Long Game in the Clouds

Snowflake isn't printing profits yet, but that's because it's scaling at a rapid pace. The company is pouring resources into AI tools and next-level infrastructure to stay ahead of everyone chasing cloud gold.

Instead of cutting corners, it's doubling down on performance, security, and flexibility. That's the kind of foundation that turns a solid company into an industry backbone.

The Payoff Is Loading

Snowflake's client list reads like a Fortune 500 reunion, streaming giants, automakers, and even OpenAI. Every new partnership adds fuel to its momentum.

If you're looking at where tech's next growth wave will store all that data, keep your eyes on Snowflake.

You might not see its logo everywhere, but you're definitely living in its cloud.

👉 Click here to get our closing report to your cell for free!

Boqii Holding [BQ] $14.66 (+84.63%)

Boqii rose after its pet care brand Yoken partnered with high-end hotels to launch co-branded, pet-friendly travel experiences, tapping into China’s booming pet tourism trend.

Emergent BioSolutions Inc [EBS] $12.84 (+36.66%)

Emergent surged after posting an unexpected quarterly profit of $1.06 per share, beating estimates by over 980% and easing investor concerns around its turnaround.

Formfactor Inc [FORM] $59.25 (+24.16%)

FormFactor rallied after beating Q3 expectations and issuing upbeat guidance that pointed to accelerating semiconductor testing demand.

FMC Corp [FMC] $15.54 (-46.49%)

FMC collapsed after a massive revenue miss tied to one-time India actions and competitive pricing pressure, with GAAP results swinging to a steep $4.52 loss per share.

Thryv Holdings Inc [THRY] $8.17 (-30.17%)

Thryv tumbled after missing earnings expectations by nearly 47%, marking its third straight quarterly miss and raising execution concerns.

Apellis Pharmaceuticals Inc [APLS] $20.73 (-31.02%)

Apellis sank over 21% despite an earnings beat, as soft forward guidance and projected losses renewed fears around long-term profitability.

Timing can make all the difference in the market.

A select group of stocks has recently risen to the top based on a proven ranking system that’s outperformed the S&P 500 for decades.

These picks aren’t random — fewer than 5% of all stocks qualify for this elite list.

Each one carries strong potential for significant short-term gains.

Before placing your next trade, it may be worth seeing which stocks made the cut.

Click Now to Access the 7 Best Stocks

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.